5-Amino-1MQ dosage chart by form

The three rows aren't three choices, they're three claims that circulate, and the first two belong to different products. 5-Amino-1MQ isn't a peptide, even though it's sold beside them. It's a small synthetic molecule, and the 5-Amino-1MQ page covers what it does. Read the source column, because every number here is convention rather than a trial result. Background is on the 5-Amino-1MQ page.

The vendors we track sell it as a freeze-dried powder in a vial, with 50 mg the most common size and smaller and larger vials also listed. You mix it with bacteriostatic water, which is sterile water with a preservative so one vial can be drawn from more than once. The table shows units on a U-100 syringe, which holds 100 units in 1 mL, for 1, 2 and 3 mL of water.

These are the injected amounts only. They don't apply to capsules.

For any other vial, water or amount, the reconstitution calculator does the same math.

Capsules are sold as a bottle of many doses, and the convention on those pages is 50 to 150 mg a day. A 50 mg figure on a capsule page means one capsule from a bottle. The same 50 mg on a vial is the entire vial, so applying a capsule number to a vial would use it up in a day. That's the mistake the chart separates the two to prevent.

The 150 to 500 mcg figure is the third claim, and it fails a check against its own page. Several sites quote it next to the claim that a 50 mg vial lasts 10 to 20 days. A 50 mg vial is 50,000 mcg, so at 500 mcg a day that's 100 days, and at 150 mcg a day about 333. For the vial to run out in 10 to 20 days the daily amount has to be 2.5 to 5 mg. The two claims describe different protocols that got copied onto one page, and no research settles which is right.

Once a day. The injected pattern on dosing sites is one injection a day under the skin, in the abdomen, outer thigh or back of the upper arm, with the spot rotated because a mild sting is often reported.

Mornings for capsules. Capsule write-ups put the dose in the morning, in one or two doses.

Eight to twelve weeks, then a break. That's the course described most often, and shorter four to six week runs with a two to four week break also circulate. No study sets either. For planning, 8 weeks of injections is 140 to 280 mg, so three to six 50 mg vials, and compare vendors against that total, not one vial price. Capsules are a different cost: 50 mg a day for 12 weeks is 4,200 mg.

A mixed vial goes on a 28-day clock in the fridge the day water goes in, however much of it gets used. At 2.5 mg a day a 50 mg vial lasts 20 days, and at 5 mg a day it lasts 10, so both finish inside the clock. A 10 mg vial lasts only 4 days at 2.5 mg, so for a daily course the 50 mg size is the one that makes sense. At the 500 mcg figure a 50 mg vial would run past the clock, with about 36 mg unused when it expires on day 28.

NAD+. This is the pairing described most often. NAD+ adds more of the raw material cells use for energy, and 5-Amino-1MQ is meant to slow an enzyme that uses it up. People run each on its own schedule, usually in the morning, and no study has tested the two together. See the NAD+ dosage chart for its amounts and the NAD+ and 5-Amino-1MQ comparison.

MOTS-c and GLP-1 compounds. MOTS-c comes up as a pairing for cellular energy, and the GLP-1 compounds come up too. Neither has combination data. See the MOTS-c dosage chart for that compound's own amounts.

These are reported experiences, not findings from a study.

Stinging or irritation at the injection site that doesn't settle. The most frequently reported complaint with the injected form. People usually rotate sites more carefully or stop.

Nausea or stomach upset. Reported more with capsules. Headaches are reported with both forms.

Sleep disruption or a jittery feeling. Described occasionally, usually toward the top of whichever range is being followed, and people usually lower the amount.

Cloudy or discolored liquid. A mixed vial that was clear and has turned cloudy or changed color is generally discarded rather than used.